A newly discovered molecule increases appetite during fasting -- and decreases it during gorging. The neuron-exciting protein, named NPGL - apparently aims to maintain body mass at a constant, come feast or famine. An evolutionary masterstroke, but not great news for those looking to trim down -- or beef up for the summer.
Up until now, scientists knew that leptin -- a hormone released by fatty tissue, reduces appetite, while ghrelin -- a hormone released by stomach tissue makes us want to eat more. These hormones, in turn, activate a host of neurons in the brain's hypothalamus -- the body's energy control center.
The discovery of NPGL shows that hunger and energy consumption mechanisms are even more complex than we realized -- and that NPGL plays a central role in what were thought to be well-understood processes.
Researchers first discovered NPGL in chickens after noticing that growing birds grew larger irrespective of diet -- suggesting there was more to energy metabolism than meets the eye. Intrigued, the researchers performed a DNA database search to see if mammals might also possess this elusive substance. They found that it exists in all vertebrates - including humans.
In order to investigate its role, if any, in mammals, the team fed three groups of mice, on three distinct diets, to see how NPGL levels are altered. The first set of mice was fed on a low-calorie diet for 24 hours. The second group was fed on a high-fat diet for 5 weeks -- and the third lucky group was fed on a high-fat diet, but for an extended period of 13 weeks.
The mice fed on a low calorie diet were found to experience an extreme increase in NPGL expression, while the 5-week high-fat-diet group saw a large decrease in NPGL expression.
Further analysis found that mice possess NPGL, and its associated neuron network, in the exact same locations of the brain as those regions already known to control appetite suppression and energy use.
Researchers proposes that NPGL plays a vital role in these mechanisms -- increasing appetite when energy levels fall and reducing appetite when an energy overload is detected -- together, helping to keep us at a healthy and functioning weight, and more importantly alive!
As NPGL levels greatly increased in mice exposed to a low calorie diet, researchers believes it is an appetite promoter, working in opposition to appetite suppressing hormones such as leptin. Backing this hypothesis up, it was found that mice directly injected with NPGL exhibited a voracious appetite.
Interestingly NPGL levels, which plummeted in the 5-week-long high-fat-diet mice - fell back to normal levels in mice who gorged themselves for the longer period of 13 weeks.
It is proposed that exposure to high-fat diets for long periods of time lead to insensitivity to leptin's appetite-suppressing effects, and so NPGL -- even at normal levels - leads to weight gain and obesity, showing that the body can only do so much to keep our weight in check.
Senior author says that further study is required to understand the interaction of previously known appetite mechanisms with this new kid on the homeostasis block. It does seem however, that we still have a lot to learn about appetite, hunger, and energy consumption. It is hoped that this study into mammalian NPGL adds another piece to the puzzle.
What is certain -- but you knew this already - is that dieting is difficult. The discovery and study of mammalian NPGL helps explain why, and provides a plausible excuse for those whose good intentions fall short.
Why we can't lose weight easily - a new protein in appetite control mix might explain
- 1,452 views
- Added
Edited
Latest News
A signaling molecule that potently stimulates hair growth
New pathway for accumulation of age-promoting 'zombie cells'
Protecting the brain from dementia-inducing abnormal protein aggregates
Why many cancer cells need to import fat
Role of nonsense-mediated mRNA decay (NMD) in fragile X-syndrome
Other Top Stories
Faster genome analysis using smart phone!
Combined visual and auditory treatment ameliorates Alzheimer's-associated pathology and improves cognition
Single neuron anatomy of the brain!
A brain-computer interface (BCI) based neurofeedback to modify an individual's arousal state
Predicting cognitive development at age 2 using AI and MRI
Protocols
Light and electron microscopic imaging of synaptic vesicle endocytosis at mouse hippocampal cultures
FLAMBE: A kinetic fluorescence polarization assay to study activation of monomeric BAX
Single-cell mass spectrometry
A behavioral paradigm for measuring perceptual distances in mice
Rapid detection of an Ebola biomarker with optical microring resonators
Publications
Cough hypersensitivity and chronic cough
Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening
The why and how of adaptive immune responses in ischemic cardiovascular disease
Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's d…
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER